AminaAshrafChaudhryMDMPH MBA(She/Her)

PubMed

• 2 citations
  Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices
  Denis G. Antoine, Sean Heffernan, Amina Chaudhry, Van L. King, Eric C. Strain> ;Addictive Disorders & Their Treatment. 2016 Dec 1
• 39 citations
  The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.
  E. Jennifer Edelman, Tongtan Chantarat, Sarah Caffrey, Amina Chaudhry, Patrick G. O'Connor, Linda Weiss, David A. Fiellin, Lynn E. Fiellin> ;Drug and Alcohol Dependence. 2014 Jun 1
• 26 citations
  Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.
  Dennis C. Turk, Alec B. O'Connor, Robert H. Dworkin, Amina Chaudhry, Nathaniel P. Katz, Edgar H. Adams, John S. Brownstein, Sandra D. Comer, Richard C. Dart, Nabarun D...> ;Pain. 2012 Oct 1
• 41 citations
  Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy
  Maria Salgado, S. Alireza Rabi, Karen A. O'Connell, Robert W. Buckheit, Justin R. Bailey, Amina Chaudhry, Autumn Breaud, Mark A. Marzinke, William Clarke, Joseph B. Ma...> ;Retrovirology. 2011 Dec 5
• 74 citations
  Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
  David A. Fiellin, Linda Weiss, Michael Botsko, James E. Egan, Frederick L. Altice, Lauri Bazerman, Amina Chaudhry, Chinazo O. Cunningham, Marc N. Gourevitch, Paula J. ...> ;Journal of Acquired Immune Deficiency Syndromes. 2011 Mar 1
• 28 citations
  Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
  Amina Chaudhry, Michael Botsko, Linda Weiss, James E. Egan, Jennifer A. Mitty, Barbara Estrada, Gregory M. Lucas, Tanita Woodson, Timothy P. Flanigan, David A. Fiellin> ;Journal of Acquired Immune Deficiency Syndromes. 2011 Mar 1
• 95 citations
  Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program: A Randomized Trial
  Gregory M. Lucas, Amina Chaudhry, Jeffrey Hsu, Tanita Woodson, Bryan Lau, Yngvild Olsen, Jeanne C. Keruly, David A. Fiellin, Ruth Finkelstein, Patricia Barditch-Crovo,...> ;Annals of Internal Medicine. 2010 Jun 1
• 49 citations
  Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.
  Amina Chaudhry, Mark S. Sulkowski, Geetanjali Chander, Richard D. Moore> ;HIV Medicine. 2009 Mar 1
• Update in HIV Medicine for the Generalist
  Amina Chaudhry, Gail Berkenblit, Allen L. Gifford, Joseph Cofrancesco, James M. Sosman, Lynn E. Sullivan> ;Journal of General Internal Medicine. 2009 Feb 1
• 202 citations
  Association between alcohol consumption and both osteoporotic fracture and bone density.
  Karina M. Berg, Hillary V. Kunins, Jeffrey L. Jackson, Shadi Nahvi, Amina Chaudhry, Kenneth A. Harris, Rubina Malik, Julia H. Arnsten> ;The American Journal of Medicine. 2008 May 1
• Join now to see all

Journal Articles

• HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers  
  Mayer KH, Crawford P , Dant L , Gillespie S , Singal R , Vandermeer M , Muench J , Long T , Quach T , Chaudhry A , Crane HM , Lembo D , Mills R , McBurnie MA, AIDS Patient Care STDS, 1/1/2016
• Age and Gender Considerations for Technology-assisted Delivery of Therapy for Substance Use Disorder Treatment: A Patient Survey of Access to Electronic Devices  
  Antoine DG, Heffernan S, Chaudhry A , King V, Strain EC, Addictive Disorders & Their Treatment, 1/1/2016
• The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients  
  Edelman EJ, Chantarat T, Caffrey S, Chaudhry A , O�Connor PG, Weiss L, Fiellin DA, Fiellin LE, Drug Alcohol Depend, 1/1/2014
• Drug Treatment Outcomes among HIV-Infected Opioid Dependent Patients Receiving Buprenorphine/naloxone  
  Fiellin DA, Weiss L, Botsko B, Egan JE, Altice FL, Bazerman LB, Chaudhry A , Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG and the BH..., J Acquir Immune Defic Syndr, 1/1/2011
• Join now to see all

Lectures

• Challenges and Opportunities: Primary Care and HIV 
  Rio de Janeiro, Brazil - 1/1/2012
• Caring for HIV-Positive Women 
  Baltimore, MD - 1/1/2012
• Update in HIV Medicine for the Generalist 
  1/1/2011